ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

RVMD Revolution Medicines Inc

40,90
1,71 (4,36%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Revolution Medicines Inc RVMD NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
1,71 4,36% 40,90 06:00:07
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
40,00 39,10 40,21 40,20 39,19
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
01.5.202422:05GLOBERevolution Medicines to Report Financial Results for First..
09.4.202421:34GLOBERevolution Medicines Announces Publication on the Discovery..
08.4.202417:36GLOBERevolution Medicines Announces Publications on the Discovery..
04.4.202422:05GLOBERevolution Medicines to Participate in Upcoming Investor..
28.3.202421:05GLOBERevolution Medicines to Deliver Multiple Presentations at..
05.3.202422:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202422:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202422:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.3.202423:23EDGAR2Form S-3ASR - Automatic shelf registration statement of..
26.2.202423:04EDGAR2Form S-8 - Securities to be offered to employees in employee..
26.2.202422:05GLOBERevolution Medicines Reports Fourth Quarter and Full Year..
26.2.202422:04EDGAR2Form 8-K - Current report
20.2.202422:05GLOBERevolution Medicines to Report Financial Results for Fourth..
09.2.202423:22EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01.2.202422:05GLOBERevolution Medicines to Participate in Upcoming Investor..
24.1.202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.1.202422:18EDGAR2Form 144 - Report of proposed sale of securities
09.1.202420:15EDGAR2Form 8-K - Current report
04.1.202413:00GLOBERevolution Medicines to Present at 42nd Annual J.P...
20.12.202323:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.12.202323:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.12.202300:22EDGAR2Form 144 - Report of proposed sale of securities
14.12.202323:48EDGAR2Form 144 - Report of proposed sale of securities
21.11.202300:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.11.202322:14EDGAR2Form 144 - Report of proposed sale of securities
16.11.202320:58EDGAR2Form CERT - Certification by an exchange approving..
15.11.202322:04EDGAR2Form 8-A12B - Registration of securities [Section 12(b)]
15.11.202302:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.11.202302:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.11.202302:13EDGAR2Form 3 - Initial statement of beneficial ownership of..
09.11.202315:20EDGAR2Form 8-K - Current report
09.11.202315:10GLOBERevolution Medicines Completes Acquisition of EQRx
08.11.202317:30GLOBERevolution Medicines and EQRx Stockholders Approve EQRx..
06.11.202322:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06.11.202322:05GLOBERevolution Medicines Reports Third Quarter 2023 Financial..
06.11.202322:05EDGAR2Form 8-K - Current report
01.11.202312:15EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
01.11.202312:11EDGAR2Form 425 - Prospectuses and communications, business..
01.11.202312:08EDGAR2Form 8-K - Current report
01.11.202312:00GLOBELeading Independent Proxy Advisory Firms ISS and Glass Lewis..
31.10.202321:15GLOBERevolution Medicines to Report Financial Results for Third..
24.10.202300:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.10.202312:13EDGAR2Form 425 - Prospectuses and communications, business..
23.10.202312:11EDGAR2Form 8-K - Current report
22.10.202308:30GLOBERevolution Medicines Presents Promising Clinical Activity..
13.10.202317:54EDGAR2Form 8-K - Current report
13.10.202317:50GLOBERevolution Medicines Presents Encouraging Clinical Data for..
04.10.202322:05GLOBERevolution Medicines to Present New Clinical Data at Major..
02.10.202322:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.9.202322:19EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock